Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1607
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBL0120006-
dc.date.accessioned2024-05-06T07:06:44Z-
dc.date.available2024-05-06T07:06:44Z-
dc.date.issued2023-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/1607-
dc.description.abstractIntroduction: Adhesive Capsulitis is a painful musculoskeletal condition of the shoulder that affects many people. It is a common disease with a prevalence rate of 2–10 % in outpatients of orthopedic, rheumatologic, and physiotherapy clinics. The disease begins spontaneously and its gradual progress leads to shoulder pain and restriction in both active and passive movements of the glenohumeral joint. Although much work has been done to treat the disease, the results of nonoperative treatment of adhesive capsulitis are not satisfactory. Very little literature is available on the effect of calcitonin in shoulder adhesive capsulitis, a proper randomized controlled trial is the need of the hour. Aim: The aim of this study is to evaluate the effect of calcitonin in adhesive capsulitis and study its risk factors.en_US
dc.language.isoen_USen_US
dc.publisherKLE Academy of Higher Education and Research, Belagavien_US
dc.subjectshoulder, adhesive capsulitis, calcitonin, frozen, physiotherapy, SPADI, ROMen_US
dc.titleProspective Randomized controlled trial on the effect of calcitonin in shoulder adhesive capsulitisen_US
dc.typeDissertationsen_US
Appears in Collections:Orthopaedics MS

Files in This Item:
File Description SizeFormat 
BL0120006.pdf3.32 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.